Literature DB >> 10388469

Detection of five rare cystic fibrosis mutations peculiar to Southern Italy: implications in screening for the disease and phenotype characterization for patients with homozygote mutations.

G Castaldo1, A Fuccio, C Cazeneuve, L Picci, D Salvatore, V Raia, M Scarpa, M Goossens, F Salvatore.   

Abstract

BACKGROUND: The search for the eight most frequent mutations (i.e., DeltaF508, G542X, W1282X, N1303K, 1717-1G-->A, R553X, 2183AA-->G, and I148T) by allele-specific oligonucleotide dot-blot analysis revealed 78% of 396 cystic fibrosis alleles in Southern Italy. The observation of frequent haplotypes on the unidentified cystic fibrosis alleles suggested that a few mutations could account for a large number of unidentified alleles.
METHODS: We screened most of the coding sequence of the cystic fibrosis transmembrane regulator gene by denaturing gradient gel electrophoresis to determine the spectrum of these mutations in 68 unrelated cystic fibrosis patients bearing one or both unidentified mutations.
RESULTS: The screening revealed five mutations, R1158X, 711+1G-->T, 4016insT, L1065P, and G1244E, each of which had a frequency of 1.3-1.8% (7% collectively). The 7% increase in the detection rate (85% vs 78%) reduces by >50% the residual risk of being cystic fibrosis carriers for couples who had tested negative by molecular analysis. We therefore designed a second allele-specific oligonucleotide set to analyze the five mutations. Among the patients analyzed, one patient homozygous for the L1065P mutation expressed a mild pulmonary and intestinal form of the disease with pancreatic insufficiency. Two other patients, homozygous for mutations R1158X and 4016insT, both expressed a severe cystic fibrosis phenotype.
CONCLUSIONS: Five cystic fibrosis mutations are peculiar to patients from Southern Italy. The method described for their analysis is efficient, inexpensive, and can be semi-automated by use of a robotic workstation. The results obtained in patients from Southern Italy may have an impact on laboratories in other countries, given the large migrations of populations from Southern Italy to other countries in the last two centuries.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10388469

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  5 in total

Review 1.  Genetic diseases that predispose to early liver cirrhosis.

Authors:  Manuela Scorza; Ausilia Elce; Federica Zarrilli; Renato Liguori; Felice Amato; Giuseppe Castaldo
Journal:  Int J Hepatol       Date:  2014-07-14

2.  S737F is a new CFTR mutation typical of patients originally from the Tuscany region in Italy.

Authors:  Vito Terlizzi; Antonella Miriam Di Lullo; Marika Comegna; Claudia Centrone; Elisabetta Pelo; Giuseppe Castaldo; Valeria Raia; Cesare Braggion
Journal:  Ital J Pediatr       Date:  2018-01-03       Impact factor: 2.638

3.  An "ex vivo model" contributing to the diagnosis and evaluation of new drugs in cystic fibrosis.

Authors:  A M Di Lullo; M Scorza; F Amato; M Comegna; V Raia; L Maiuri; G Ilardi; E Cantone; G Castaldo; M Iengo
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-06       Impact factor: 2.124

Review 4.  An update on laboratory diagnosis of liver inherited diseases.

Authors:  Federica Zarrilli; Ausilia Elce; Manuela Scorza; Sonia Giordano; Felice Amato; Giuseppe Castaldo
Journal:  Biomed Res Int       Date:  2013-10-08       Impact factor: 3.411

5.  Analysis of cystic fibrosis gene mutations in children with cystic fibrosis and in 964 infertile couples within the region of Basilicata, Italy: a research study.

Authors:  Domenico Dell'Edera; Michele Benedetto; Gemma Gadaleta; Domenico Carone; Donatello Salvatore; Antonella Angione; Massimiliano Gallo; Michele Milo; Maria Laura Pisaturo; Giuseppe Di Pierro; Eleonora Mazzone; Annunziata Anna Epifania
Journal:  J Med Case Rep       Date:  2014-10-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.